HEADER SIGNALING PROTEIN 03-JUL-23 8PO3 TITLE DISCOVERY AND OPTIMISATION OF POTENT, EFFICACIOUS AND SELECTIVE TITLE 2 INHIBITORS TARGETING EGFR EXON20 INSERTION MUTATIONS. COMPOUND 18 TITLE 3 BOUND TO EGFR[V948R] COMPND MOL_ID: 1; COMPND 2 MOLECULE: EPIDERMAL GROWTH FACTOR RECEPTOR; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: PROTO-ONCOGENE C-ERBB-1,RECEPTOR TYROSINE-PROTEIN KINASE COMPND 5 ERBB-1; COMPND 6 EC: 2.7.10.1; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: EGFR, ERBB, ERBB1, HER1; SOURCE 6 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA ASCOVIRUS 1D; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 1076708 KEYWDS EGFR, EXON 20 INSERTION, NON-SMALL CELL LUNG CANCER, ONCOLOGY, KEYWDS 2 SIGNALING PROTEIN EXPDTA X-RAY DIFFRACTION AUTHOR D.HARGREAVES REVDAT 3 06-NOV-24 8PO3 1 REMARK REVDAT 2 19-JUN-24 8PO3 1 JRNL REVDAT 1 05-JUN-24 8PO3 0 JRNL AUTH C.THOMSON,P.BARTON,E.BRAYBROOKE,N.COLCLOUGH,Z.DONG,L.EVANS, JRNL AUTH 2 N.FLOC'H,C.GUEROT,D.HARGREAVES,P.KHURANA,S.LI,X.LI,A.LISTER, JRNL AUTH 3 W.MCCOULL,L.MCWILLIAMS,J.P.ORME,M.J.PACKER,A.M.SWAIH, JRNL AUTH 4 R.A.WARD,P.WINLOW,Y.YE JRNL TITL DISCOVERY AND OPTIMIZATION OF POTENT, EFFICACIOUS AND JRNL TITL 2 SELECTIVE INHIBITORS TARGETING EGFR EXON20 INSERTION JRNL TITL 3 MUTATIONS. JRNL REF J.MED.CHEM. V. 67 8988 2024 JRNL REFN ISSN 0022-2623 JRNL PMID 38770784 JRNL DOI 10.1021/ACS.JMEDCHEM.4C00227 REMARK 2 REMARK 2 RESOLUTION. 2.13 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER 2.11.8 (24-FEB-2021) REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN, REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.13 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 42.18 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.3 REMARK 3 NUMBER OF REFLECTIONS : 18712 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.222 REMARK 3 R VALUE (WORKING SET) : 0.219 REMARK 3 FREE R VALUE : 0.269 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.010 REMARK 3 FREE R VALUE TEST SET COUNT : 938 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 47 REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 2.13 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 2.15 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 99.75 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : 407 REMARK 3 BIN R VALUE (WORKING + TEST SET) : 0.2643 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 385 REMARK 3 BIN R VALUE (WORKING SET) : 0.2611 REMARK 3 BIN FREE R VALUE : 0.3168 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 5.41 REMARK 3 BIN FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2247 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 39 REMARK 3 SOLVENT ATOMS : 224 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 23.67 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -1.23320 REMARK 3 B22 (A**2) : 1.65540 REMARK 3 B33 (A**2) : -0.42230 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.280 REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : 0.283 REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : 0.218 REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : 0.251 REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : 0.210 REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.912 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.867 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 2345 ; 2.000 ; HARMONIC REMARK 3 BOND ANGLES : 3174 ; 2.000 ; HARMONIC REMARK 3 TORSION ANGLES : 836 ; 2.000 ; SINUSOIDAL REMARK 3 TRIGONAL CARBON PLANES : NULL ; NULL ; NULL REMARK 3 GENERAL PLANES : 380 ; 5.000 ; HARMONIC REMARK 3 ISOTROPIC THERMAL FACTORS : 2345 ; 10.000 ; HARMONIC REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : 303 ; 5.000 ; SEMIHARMONIC REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : 2156 ; 4.000 ; SEMIHARMONIC REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.008 REMARK 3 BOND ANGLES (DEGREES) : 0.96 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 3.21 REMARK 3 OTHER TORSION ANGLES (DEGREES) : 17.50 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 8PO3 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 11-JUL-23. REMARK 100 THE DEPOSITION ID IS D_1292131111. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 13-OCT-17 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : DIAMOND REMARK 200 BEAMLINE : I04 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.91587 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : AIMLESS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 159456 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.805 REMARK 200 RESOLUTION RANGE LOW (A) : 110.171 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 93.3 REMARK 200 DATA REDUNDANCY : 5.800 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 7.4000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.81 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.84 REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: SMALL PLATE-LIKE CRYSTALS REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 42.66 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.15 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PEG 8K 12%W/V PH 0, PCPT 0.1M PH 5.5, REMARK 280 VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 293.15K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z REMARK 290 3555 -X+1/2,Y+1/2,-Z REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 55.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 42.18000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 55.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 42.18000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 0 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 14250 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: 0.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 693 REMARK 465 SER A 694 REMARK 465 SER A 695 REMARK 465 GLY A 696 REMARK 465 GLU A 697 REMARK 465 ALA A 698 REMARK 465 PRO A 699 REMARK 465 ASN A 700 REMARK 465 GLN A 701 REMARK 465 ALA A 702 REMARK 465 LEU A 703 REMARK 465 LEU A 704 REMARK 465 ARG A 705 REMARK 465 GLY A 863 REMARK 465 ALA A 864 REMARK 465 GLU A 865 REMARK 465 GLU A 866 REMARK 465 LYS A 867 REMARK 465 GLU A 868 REMARK 465 TYR A 869 REMARK 465 HIS A 870 REMARK 465 ALA A 871 REMARK 465 GLU A 872 REMARK 465 GLY A 873 REMARK 465 GLY A 874 REMARK 465 LYS A 875 REMARK 465 MET A 987 REMARK 465 HIS A 988 REMARK 465 LEU A 989 REMARK 465 PRO A 990 REMARK 465 MET A 1002 REMARK 465 ASP A 1003 REMARK 465 GLU A 1004 REMARK 465 GLU A 1005 REMARK 465 ASP A 1006 REMARK 465 MET A 1007 REMARK 465 ASP A 1008 REMARK 465 ASP A 1009 REMARK 465 VAL A 1010 REMARK 465 VAL A 1011 REMARK 465 ASP A 1012 REMARK 465 ALA A 1013 REMARK 465 ASP A 1014 REMARK 465 GLU A 1015 REMARK 465 TYR A 1016 REMARK 465 LEU A 1017 REMARK 465 ILE A 1018 REMARK 465 PRO A 1019 REMARK 465 GLN A 1020 REMARK 465 GLN A 1021 REMARK 465 GLY A 1022 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ARG A 836 -11.07 81.25 REMARK 500 ASP A 837 44.12 -146.76 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH A1420 DISTANCE = 5.83 ANGSTROMS REMARK 525 HOH A1421 DISTANCE = 5.94 ANGSTROMS REMARK 525 HOH A1422 DISTANCE = 6.00 ANGSTROMS REMARK 525 HOH A1423 DISTANCE = 6.44 ANGSTROMS REMARK 525 HOH A1424 DISTANCE = 7.12 ANGSTROMS DBREF 8PO3 A 695 1022 UNP P00533 EGFR_HUMAN 695 1022 SEQADV 8PO3 GLY A 693 UNP P00533 EXPRESSION TAG SEQADV 8PO3 SER A 694 UNP P00533 EXPRESSION TAG SEQADV 8PO3 ARG A 948 UNP P00533 VAL 948 ENGINEERED MUTATION SEQRES 1 A 330 GLY SER SER GLY GLU ALA PRO ASN GLN ALA LEU LEU ARG SEQRES 2 A 330 ILE LEU LYS GLU THR GLU PHE LYS LYS ILE LYS VAL LEU SEQRES 3 A 330 GLY SER GLY ALA PHE GLY THR VAL TYR LYS GLY LEU TRP SEQRES 4 A 330 ILE PRO GLU GLY GLU LYS VAL LYS ILE PRO VAL ALA ILE SEQRES 5 A 330 LYS GLU LEU ARG GLU ALA THR SER PRO LYS ALA ASN LYS SEQRES 6 A 330 GLU ILE LEU ASP GLU ALA TYR VAL MET ALA SER VAL ASP SEQRES 7 A 330 ASN PRO HIS VAL CYS ARG LEU LEU GLY ILE CYS LEU THR SEQRES 8 A 330 SER THR VAL GLN LEU ILE THR GLN LEU MET PRO PHE GLY SEQRES 9 A 330 CYS LEU LEU ASP TYR VAL ARG GLU HIS LYS ASP ASN ILE SEQRES 10 A 330 GLY SER GLN TYR LEU LEU ASN TRP CYS VAL GLN ILE ALA SEQRES 11 A 330 LYS GLY MET ASN TYR LEU GLU ASP ARG ARG LEU VAL HIS SEQRES 12 A 330 ARG ASP LEU ALA ALA ARG ASN VAL LEU VAL LYS THR PRO SEQRES 13 A 330 GLN HIS VAL LYS ILE THR ASP PHE GLY LEU ALA LYS LEU SEQRES 14 A 330 LEU GLY ALA GLU GLU LYS GLU TYR HIS ALA GLU GLY GLY SEQRES 15 A 330 LYS VAL PRO ILE LYS TRP MET ALA LEU GLU SER ILE LEU SEQRES 16 A 330 HIS ARG ILE TYR THR HIS GLN SER ASP VAL TRP SER TYR SEQRES 17 A 330 GLY VAL THR VAL TRP GLU LEU MET THR PHE GLY SER LYS SEQRES 18 A 330 PRO TYR ASP GLY ILE PRO ALA SER GLU ILE SER SER ILE SEQRES 19 A 330 LEU GLU LYS GLY GLU ARG LEU PRO GLN PRO PRO ILE CYS SEQRES 20 A 330 THR ILE ASP VAL TYR MET ILE MET ARG LYS CYS TRP MET SEQRES 21 A 330 ILE ASP ALA ASP SER ARG PRO LYS PHE ARG GLU LEU ILE SEQRES 22 A 330 ILE GLU PHE SER LYS MET ALA ARG ASP PRO GLN ARG TYR SEQRES 23 A 330 LEU VAL ILE GLN GLY ASP GLU ARG MET HIS LEU PRO SER SEQRES 24 A 330 PRO THR ASP SER ASN PHE TYR ARG ALA LEU MET ASP GLU SEQRES 25 A 330 GLU ASP MET ASP ASP VAL VAL ASP ALA ASP GLU TYR LEU SEQRES 26 A 330 ILE PRO GLN GLN GLY HET 2II A1101 39 HETNAM 2II 2-METHYL-5-[[3-[1-[(3~{S})-1-PROPANOYLPYRROLIDIN-3-YL]- HETNAM 2 2II 4-PYRIDIN-4-YL-PYRAZOL-3-YL]PHENOXY]METHYL]-3~{H}- HETNAM 3 2II ISOINDOL-1-ONE FORMUL 2 2II C31 H31 N5 O3 FORMUL 3 HOH *224(H2 O) HELIX 1 AA1 LYS A 708 THR A 710 5 3 HELIX 2 AA2 SER A 752 ALA A 767 1 16 HELIX 3 AA3 CYS A 797 HIS A 805 1 9 HELIX 4 AA4 GLY A 810 ARG A 831 1 22 HELIX 5 AA5 ALA A 839 ARG A 841 5 3 HELIX 6 AA6 GLY A 857 LEU A 862 1 6 HELIX 7 AA7 PRO A 877 MET A 881 5 5 HELIX 8 AA8 ALA A 882 ARG A 889 1 8 HELIX 9 AA9 THR A 892 THR A 909 1 18 HELIX 10 AB1 PRO A 919 SER A 921 5 3 HELIX 11 AB2 GLU A 922 LYS A 929 1 8 HELIX 12 AB3 THR A 940 CYS A 950 1 11 HELIX 13 AB4 ASP A 954 ARG A 958 5 5 HELIX 14 AB5 LYS A 960 ASP A 974 1 15 HELIX 15 AB6 PRO A 975 TYR A 978 5 4 HELIX 16 AB7 PRO A 992 LEU A 1001 1 10 SHEET 1 AA1 5 PHE A 712 SER A 720 0 SHEET 2 AA1 5 GLY A 724 TRP A 731 -1 O LYS A 728 N LYS A 716 SHEET 3 AA1 5 ILE A 740 LEU A 747 -1 O VAL A 742 N GLY A 729 SHEET 4 AA1 5 GLN A 787 THR A 790 -1 O LEU A 788 N LYS A 745 SHEET 5 AA1 5 GLY A 779 CYS A 781 -1 N GLY A 779 O ILE A 789 SHEET 1 AA2 2 VAL A 843 THR A 847 0 SHEET 2 AA2 2 HIS A 850 ILE A 853 -1 O LYS A 852 N LEU A 844 LINK SG CYS A 797 C25 2II A1101 1555 1555 1.74 CRYST1 110.000 84.360 34.760 90.00 90.00 90.00 P 21 21 2 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.009091 0.000000 0.000000 0.00000 SCALE2 0.000000 0.011854 0.000000 0.00000 SCALE3 0.000000 0.000000 0.028769 0.00000